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Summary
Background: Polymorphisms in the vitamin D receptor (VDR) gene have been associated with
susceptibility to several diseases, including type 1 diabetes (T1D) and infections. In this study we
investigated whether VDR gene polymorphisms influence nasal carriage of Staphylococcus aureus
in individuals with T1D.
Methods: In 93 T1D patients, VDR polymorphisms on FokI F>f, BsmI B>b, ApaI A>a, and TaqI T>t
were determined in DNA extracted from peripheral blood leukocytes, and a nasal swab was
obtained to detect colonization by S. aureus. A repeat swab was obtained in 76/93 subjects for
the estimation of persistent S. aureus carriage.
Results: The prevalence of S. aureus nasal colonization was 31.2% and the prevalence of
persistent carriage was 25%. The presence of TaqI T allele was related to higher rates of S.
aureus colonization, and TaqI TT homozygotes were more colonized (48.5% vs. 21.7%; p 0.007; OR
3.40, 95% CI 1.36—8.52) and more persistent carriers (37.9% vs. 17.0%; p 0.039; OR 2.98, 95% CI
1.02—8.67). The presence of ApaI A allele was related to lower rates of S. aureus colonization,
and ApaI AA homozygotes were less colonized (17.6% vs. 39.0%; p 0.026; OR 0.34, 95% CI 0.12—
0.94) and less persistent carriers (11.5% vs. 32%; p 0.043; OR 0.28, 95% CI 0.07—1.06). No
differences were observed for BsmI and FokI genotypes.
Conclusions: Our findings suggest that VDR polymorphisms may be associated with nasal carriage
of S. aureus in individuals with T1D, and further contribute to the better understanding of the
immunomodulatory role of vitamin D in the human host’s response and susceptibility to infection.
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The vitamin D endocrine system has pleiotropic effects on
various processes including calcium absorption and bone
biology, cell growth and differentiation, and modulation of
the immune system.1,2 Vitamin D mediates its actions by
binding to the vitamin D receptor (VDR), which is a soluble
protein present in various tissues and in Tand B lymphocytes,
monocytes, and macrophages.1—4 Polymorphisms in the
human VDR gene have been associated with several diseases
including type 1 diabetes (T1D),2,5—7 and with susceptibility
to several bacterial and viral infections.3,4,8—12
Staphylococcus aureus is a major pathogen for humans
with increasing resistance to antibiotics. The anterior nares
are the primary ecological reservoir of S. aureus, and nasal
carriage has been related to progress to staphylococcal
disease.13—20 The host’s response seems to be crucial in S.
aureus nasal colonization and carriage, but little is known in
this field.20 Vitamin D metabolites are known to affect
macrophage activation, and neutrophils have been demon-
strated to express functional VDR,10,21 hence VDR gene
polymorphisms may affect colonization and infection by
microorganisms such as S. aureus that might behave as an
intracellular pathogen.
Individuals with T1D are considered to be susceptible to
infections in terms of frequency, severity, and complica-
tions, including infections by S. aureus.13,15,16,22 Although
VDR polymorphisms are related both with T1D and suscept-
ibility to infection, and T1D is further associated to S.
aureus infection, to date no study has investigated poten-
tial links between VDR polymorphisms on the one hand and
T1D and S. aureus disease or carriage on the other. In this
study we investigated whether the four most commonly
studied polymorphisms in the VDR gene, i.e., FokI F>f,
BsmI B>b, ApaI A>a, and TaqI T>t are associated with
colonization by and persistent carriage of S. aureus in
individuals with T1D.
Patients and methods
Patient recruitment
The study group consisted of a cohort of 93 T1D patients,
followed up at the outpatient diabetic clinic of the Depart-
ment of Pediatrics, University Hospital of Heraklion, Crete,
Greece. This T1D outpatient clinic is the only one on the
island of Crete. Diagnosis of T1D follows the American Dia-
betes Association guidelines.23 The study protocol was
approved by the institutional committees of the University
Hospital of Heraklion and the Medical School, University of
Crete.
S. aureus carriage
Nasal specimens were obtained by rotating a sterile fiber-
tipped swab four times in both anterior nares of each enrolled
individual. The swabs were immediately placed in Amies
transport medium (BioMerieux, Marcy L’Etoile, France) and
kept at 4 8C before being inoculated onto mannitol salt agar
and Columbia agar with 5% sheep blood. The culture plates
were incubated at 36 8C for 48 hours. S. aureuswas identifiedon the basis of colony morphology, Gram stain, catalase and
coagulase test, and the API 20 Staph system (BioMerieux). A
second nasal swab culture was obtained after a minimum
interval of 3 months. Subjects were classified as persistent
carriers if both cultures were positive, as non-carriers if both
cultures were negative, and as intermittent carriers in cases
where one culture was positive and the other was nega-
tive.13,15,17—20,24 Individuals with a single nasal swab avail-
able were excluded from further analysis of persistent
carriage.
DNA analysis
Whole blood was collected in EDTA-containing tubes, and
genomic DNAwas isolated from peripheral blood leukocytes
using the Puregene kit (Gentra Systems, Minnesota, USA).
The extracted DNA was stored at 20 8C until analysis. DNA
was amplified with standard PCR techniques. The cDNA of
the human VDR (vitamin D 1,25-dihydroxyvitamin D3 recep-
tor) sequence (GenBank accession number J03258) was
used to design primers for PCR amplification of the frag-
ments, as shown in Table 1. Both undigested and digested
PCR products were visualized on 2.5% agarose gels stained
with ethidium bromide. Genotypes were determined
according to the presence or absence of an appropriate
restriction site, and alleles were designated respective to
actual base change according to the dbSNP (http://
www.ncbi.nlm.nih.gov/projects/SNP/). Genotypes were
scored blindly and analysis of all ambiguous samples was
repeated. Moreover, 10% of the samples were amplified
twice to check the accuracy of results. The selection of
the four enzyme sites followed previous protocols, and the
established nomenclature for restriction fragment length
polymorphism alleles was used in this study.2,7,10—12,18 The
lowercase allele represents the presence of the restriction
site ( f: FokI, b: BsmI, a: ApaI, or t: TaqI) and the uppercase
allele represents the absence of the restriction site (F, B, A,
or T, respectively).25 Allele types, SNP reference numbers,
and PCR conditions for all the analyzed polymorphisms are
shown in Table 2.
Confirmation of polymorphisms by direct
sequencing
Selected PCR amplified fragments from the four VDR exam-
ined polymorphisms, corresponding to heterozygous or
mutant homozygous genotypes, were completely sequenced,
both strands, in a LiCor 4200L sequencer at the laboratory of
microchemistry (IMBB-FORTH, Crete, Greece) in order to
confirm that the amplified products represent genuine VDR
regions.
Statistical analysis
Statistical analysis was based on contingency tables, includ-
ing calculations of odds ratio (OR) and of the lower and upper
limits of the 95% confidence interval (95% CI). The one-tailed
Fisher’s exact test was applied to determine whether dis-
tributions of categorized variables between the groups were
significant. The Hardy—Weinberg equilibrium was tested by
comparing expected and observed genotype frequencies by
Table 1 PCR primers designed to amplify fragments harboring the vitamin D receptor single nucleotide polymorphisms (SNPs)
SNP PCR primer Fragment size
ApaI Forward (50—30) CAG AGC ATG GAC AGG GAG CAA 740 bp uncleaved
Reverse (30—50) GCA ACT CCT CAT GGC TGA GGT C CTC 530 bp, 210 bp
BsmI Forward (50—30) CAA CCA AGA CTA CAA GTA CCG CGT CAG TGA 825 bp uncleaved
Reverse (30—50) AAC CAG CGG GAA GAG GTC AAG GG 650 bp, 175 bp
FokI Forward (50—30) AGC TGG CCC TGG CAC TGA CTC TGC TCT 265 bp uncleaved
Reverse (30—50) ATG GAA ACA CCT TGC TTC TTC TCC CTC 196 bp, 69 bp
TaqI Forward (50—30) CAG AGC ATG GAC AGG GAG CAA 740 bp uncleaved
Reverse (30—50) GCA ACT CCT CAT GGC TGA GGT C CTC 495 bp, 245 bp or 290 bp,
245 bp and 205 bp
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considered to be significant.
Results
During the 21-year period, 1986—2006, 147 individuals were
diagnosed with T1D and followed-up at the outpatient clinic.
Of these, 93 (63.3%) were enrolled in this study. The 93
individuals (43 female and 50 male) were aged 3.3 to 25.3
(mean 12.3, median 12.4) years, and the duration of T1D
from diagnosis ranged from 0.1 to 17.0 (mean 4.4, median
2.8) years.
VDR gene FokI, BsmI, ApaI, and TaqI genotypes and allele
frequencies are shown in Table 3. In the initial nasal swab
sampling, 29/93 individuals (31.2%) were found to be colo-
nized by S. aureus. Among the 76 individuals from whom a
second culture was obtained, 19 (25%) were defined as
persistent S. aureus carriers, 21 (27.6%) as intermittent
carriers, and 36 (47.4%) as non-carriers for S. aureus.
VDR polymorphisms and initial S. aureus carriage
As shown in Table 3, S. aureus nasal colonization was more
common in individuals with TaqI T than t allele (37.0% vs.
20.9%; p 0.016; OR 2.22, 95% CI 1.11—4.46), and TaqI TT
homozygotes were more colonized by S. aureus than geno-Table 2 Allele types, single nucleotide polymorphism (SNP) refe
SNP Allele type Ref. number PCR conditi
ApaI a allele: T!G transition
in intron 8
rs7975232 Denaturatio
and then sa
(at 94 8C fo
(at 72 8C fo
BsmI b allele: G!A transition rs1544410 Initial heati
and then 35
(at 60 8C fo
a final exte
FokI f allele: C!T transition at the
junction of intron 1 and exon 2
rs10735810 Initial heati
(at 94 8C fo
(at 72 8C fo
TaqI t allele: silent T!C transition
in exon 9
rs731236 Denaturatio
and then sa
(at 94 8C fo
(at 72 8C fotypes TaqI tt and Tt combined (48.5% vs. 21.7%; p 0.007; OR
3.40, 95% CI 1.36—8.52). S. aureus nasal colonization was less
common in individuals with ApaI A rather than a allele,
although not at a statistically significant level (27.3% vs.
38.5%; p 0.081; OR 0.60, 95% CI 0.31—1.14); furthermore
ApaI AA homozygotes were less colonized than ApaI aa and Aa
genotypes combined (17.6% vs. 39.0%; p 0.026; OR 0.34, 95%
CI 0.12—0.94). No significant differences were observed for
BsmI and FokI genotypes.
VDR polymorphisms and persistent S. aureus
carriage
As shown in Table 4, S. aureus persistent nasal colonization
was more common in individuals with TaqI T than t allele
(29.3% vs. 17.0%), although at a marginally significant level
( p 0.068; OR 2.03, 95% CI 0.88—4.68); furthermore TaqI TT
homozygotes were persistently colonized by S. aureus more
than genotypes TaqI tt and Tt combined (37.9% vs. 17.0%; p
0.039; OR 2.98, 95% CI 1.02—8.67). S. aureus nasal coloniza-
tion was more common in individuals with ApaI a than A
allele, although not at a significant level (21.9% vs. 30.4%; p
0.17; OR 0.64, 95% CI 0.30—1.36); furthermore, ApaI AA
homozygotes were less persistent carriers than ApaI aa and
Aa genotypes combined (11.5% vs. 32%; p 0.043; OR 0.28, 95%
CI 0.07—1.06). No significant differences were observed for
BsmI and FokI genotypes.rence numbers, and PCR conditions
ons
n at 94 8C for 5 min, followed by addition of the polymerase,
mples were exposed to 35 cycles of denaturing
r 30 s), annealing (at 70 8C for 30 s), and chain extension
r 1 min), followed by a final extension step at 72 8C for 7 min
ng at 94 8C for 5 min, followed by addition of the polymerase
cycles of denaturing (at 94 8C for 15 s), annealing
r 30 s), and chain extension (at 72 8C for 30 s), followed by
nsion step at 72 8C for 7 min
ng at 94 8C for 5 min, followed by 35 cycles of denaturing
r 15 s), annealing (at 60 8C for 30 s), and chain extension
r 30 s), followed by a final extension step at 72 8C for 7 min
n at 94 8C for 5 min, followed by addition of the polymerase,
mples were exposed to 35 cycles of denaturing
r 30 s), annealing (at 70 8C for 30 s), and chain extension
r 1 min), followed by a final extension step at 72 8C for 7 min
Table 3 Distribution of VDR genotype and haplotype frequencies in 93 individuals with type 1 diabetes as related to S. aureus nasal
colonization
VDR gene
polymorphism
HWEa p-value S. aureus
colonized (%)
S. aureus
non-colonized (%)
Total p-Value;
OR (95% CI)b
FokI
Genotype 0.67 (0.91) NS
ff 0 (0) 7 (100) 7
Ff 16 (40) 24 (60) 40
FF 13 (28.3) 33 (71.7) 46
Allele NS
f 16 (29.6) 38 (70.4) 54
F 42 (31.8) 90 (68.2) 132
BsmI
Genotype 0.12 (0.30) NS
bb 6 (31.6) 13 (68.4) 19
Bb 19 (35.2) 35 (64.8) 54
BB 4 (20) 16 (80) 20
Allele NS
b 31 (33.7) 61 (66.3) 92
B 27 (28.7) 67 (71.3) 94
ApaI
Genotype 0.01 (0.05) 0.026; 0.34 (0.12—0.94) c
aa 2 (33.3) 4 (66.7) 6
Aa 21 (39.6) 32 (60.4) 53
AA 6 (17.6) 28 (82.4) 34
Allele 0.081; 0.60 (0.31—1.14) d
a 25 (38.5) 40 (61.5) 65
A 33 (27.3) 88 (72.7) 121
TaqI
Genotype 0.02 (0.07) 0.007; 3.40 (1.36—8.52) e
tt 1 (14.3) 6 (85.7) 7
Tt 12 (22.6) 41 (77.4) 53
TT 16 (48.5) 17 (51.5) 33
Allele 0.016; 2.22 (1.11—4.46) f
t 14 (20.9) 53 (79.1) 67
T 44 (37.0) 75 (63.0) 119
Total patients 29 (31.2) 64 (68.8) 93
Total alleles 58 (31.2) 128 (68.8) 186
VDR, vitamin D receptor; NS, not significant; OR, odds ratio; CI, confidence interval.
a Hardy—Weinberg equilibrium (calculations with 1 degree of freedom; in parentheses values after calculation with 2 degrees of freedom).
b p-Values and odds ratios calculated for colonized vs. non-colonized T1D individuals.
c (ApaI aa + ApaI Aa) vs. ApaI AA.
d A allele vs. a allele.
e TaqI TT vs. (TaqI tt + TaqI Tt).
f T allele vs. t allele.
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Our findings suggest that two VDR polymorphisms, both
located in the 30 region of the VDR gene, are related to
colonization by and persistent nasal carriage of S. aureus in
individuals with T1D. In this study we focused on both initial
colonization and persistent carriage, as persistent carriers
have higher S. aureus loads and a higher risk of acquiring S.
aureus infection.13 The rates of colonization and persistent
S. aureus carriage in the study population (31% and
25%, respectively) are consistent with the ranges reported
elsewhere.15—19,26The ability of S. aureus to colonize the human host and
progress to infection depends both on virulence properties of
the invading strain and on the individual host’s response. Not
much is known on the intrinsic properties of S. aureus strains
that facilitate colonization and long-term carriage.18—20 By
contrast, evidence is emerging and pointing to host genetic
factors affecting S. aureus colonization and carriage.18,20,24,26
Staphylococcal carriage has long been associated with the
presence of HLA-DR3.27 In individuals with T1D, dendritic cells
have been shown to produce less interferon-a,28 and poly-
morphonuclear cells have demonstrated impaired killing func-
tion against S. aureus.16 Our findings provide evidence for
Table 4 Distribution of VDR genotype and haplotype frequencies in 76 individuals with type 1 diabetes as related to S. aureus
persistent nasal carriage
VDR gene
polymorphism
HWEa p-value Persistent
carriers (%)
Intermittent
carriers (%)
Non-carriers
(%)
Total p-Value;
OR (95% CI)b
FokI
Genotype 0.98 (1.00) NS
ff 0 (0.0) 1 (14.3) 6 (85.7) 7
Ff 11 (34.4) 9 (28.1) 12 (37.5) 32
FF 8 (21.6) 11 (29.7) 18 (48.7) 37
Allele NS
f 11 (23.9) 11 (23.9) 24 (52.2) 46
F 27 (25.5) 31 (29.2) 48 (45.3) 106
BsmI
Genotype 0.07 (0.19) NS
bb 4 (26.7) 3 (20.0) 8 (53.3) 15
Bb 13 (28.3) 13 (28.3) 20 (44.4) 46
BB 2 (13.3) 5 (33.3) 8 (53.4) 15
Allele NS
b 21 (27.6) 19 (25.0) 36 (47.4) 76
B 17 (22.4) 23 (30.3) 36 (47.3) 76
ApaI
Genotype 0.03 (0.10) 0.043; 0.28 (0.07—1.06) c
aa 1 (16.7) 3 (50.0) 2 (33.3) 6
Aa 15 (34.1) 8 (18.2) 21 (47.7) 44
AA 3 (11.5) 10 (38.5) 13 (50.0) 26
Allele 0.17; 0.64 (0.30—1.36)d
a 17 (30.4) 14 (25.0) 25 (44.6) 56
A 21 (21.9) 28 (29.2) 47 (48.9) 96
TaqI
Genotype 0.10 (0.26) 0.039; 2.98 (1.02—8.67)e
tt 1 (16.7) 2 (33.3) 3 (50.0) 6
Tt 7 (17.1) 14 (34.1) 20 (48.8) 41
TT 11 (37.9) 5 (17.2) 13 (44.8) 29
Allele 0.068; 2.03 (0.88—4.68) f
t 9 (17.0) 18 (34.0) 26 (49.0) 53
T 29 (29.3) 24 (24.2) 46 (46,5) 99
Total patients 19 (25.0) 21 (27.6) 36 (47.4) 76
Total alleles 38 (25.0) 42 (27.6) 72 (47.4) 152
VDR, vitamin D receptor; NS, not significant; OR, odds ratio; CI, confidence interval.
a Hardy—Weinberg equilibrium (calculations with 1 degree of freedom; in parentheses values after calculation with 2 degrees of freedom).
b p-Values and odds ratios calculated for persistent vs. intermittent plus non-carriage state.
c (ApaI aa + ApaI Aa) vs. ApaI AA.
d A allele vs. a allele.
e TaqI TT vs. (TaqI tt + TaqI Tt).
f T allele vs. t allele.
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Interestingly, no significant association between VDR gene
polymorphism and S. aureus nasal carriage status was demon-
strated ina studywithhealthyvolunteers.17Hence,weassume
that it is in conditions with impaired immunity, such as in T1D,
where VDR polymorphisms may affect susceptibility to S.
aureus colonization and carriage. VDR gene polymorphisms
may be involved in colonization by S. aureus, since vitamin D
metabolites have been shown to play a role in macrophage
activation and differentiation10,11,21 and neutrophils have
been demonstrated to play an important role in the innateimmunity against S. aureus. Cole et al.18 demonstrated that
persistent S. aureus nasal carriage is accompanied by the
release of epithelial- and neutrophil-derived host defense
peptides into nasal secretions, providing a possible explana-
tion for the failure of S. aureus clearance in individuals with
macrophage dysfunction.
The ApaI genotype has been shown to modulate suscept-
ibility to Mycobacterium malmoense3 and hepatitis B
virus,4 and the TaqI genotype susceptibility to mycobac-
teria,3,9 lower respiratory tract infections,10 and period-
ontitis.11,12 Vitamin D metabolites are known to suppress
e442 C. Panierakis et al.tumor necrosis factor-a, interleukin (IL)-1, and IL-2, to
stimulate transforming growth factor-b1 and IL-4 produc-
tion, to inhibit T cell proliferation and inflammatory activ-
ity,1 and thus to modulate Th1/Th2 balance,3 to modulate
expression of neutrophil genes, and restrict association
and invasion of macrophages by pathogens including S.
aureus.20,29 S. aureus carriage is associated with opsoniza-
tion,13,14 and persistent S. aureus nasal carriage has been
shown to be accompanied by the release of epithelial- and
neutrophil-derived peptides into nasal secretions.18 The
TaqI polymorphism has been proposed to affect VDR-
mediated production of IL-1a and IL-6 and production of
anti-proteinase TIMP-1, which is a natural inhibitor of
metalloproteinase-9.10 On the other hand, VDR gene poly-
morphisms FokI, BsmI, ApaI, and TaqI are well known to
influence the occurrence of T1D, although protective or
predisposing effects vary greatly among studies and popu-
lations worldwide.5—7
Our findings are based on a relatively small population and
need to be confirmed in larger cohorts. However, as we
enrolled the majority of T1D individuals in the island of
Crete, our study provides the benefits of a well-defined area
and of a population with one of the lowest T1D incidence
rates in Europe.30 Violation of Hardy—Weinberg equilibrium
in ApaI and TaqI polymorphisms in our study should be
attributed to the small cohort size, and to inbreeding, a
minimized migration rate, and closed gene pool of our island
population. In addition, following suggestions by Chen and
Chatterjee,31 we used a 2-degrees-of-freedom Chi-square
‘model-free’ test of association that has robust power under
unknown modes of genetic effects, and confirmed that
Hardy—Weinberg equilibrium was not violated any more
(Tables 3 and 4). Violation of Hardy—Weinberg equilibrium
has been observed in several other studies investigating VDR
polymorphisms in T1D and has been attributed to disease-
related gene, non-random mating, and common genetic
background of study populations.32—34
As polymorphisms ApaI and TaqI are probably non-func-
tional and do not modify the VDR polypeptide sequence,
linkage disequilibrium with one or more truly functional
polymorphisms elsewhere in the VDR gene is assumed to
explain the impact on VDR functionality. Research for addi-
tional polymorphisms across the VDR gene is therefore
required to verify this hypothesis. In a sequence analysis
performed in our laboratory using Genomatix (Genomatix
Software GmbH 1998—2008), the polymorphic site was not
found to disrupt any transcription factor binding site and,
therefore, it does not seem plausible that the SNPs under
study affect the expression levels of VDR. Our study was only
of a descriptive nature, and future research should include
functional tests on immune cells and focus on underlying
mechanisms and on genetic and environmental factors poten-
tially interfering in the relationship between VDR polymorph-
isms and S. aureus carriage and disease. Furthermore, future
research might use peripheral blood mononuclear cells
instead of whole blood.
Our findings suggest that genetic variation in the vita-
min D receptor gene affects nasal colonization by S. aureus
in individuals with type 1 diabetes, and further contribute
to the understanding of the immunoregulatory role of
vitamin D in the host’s response and susceptibility to
infection.Acknowledgements
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